Lung Nodule, Breast, Kidney,Parathyroid, Mediastinal, Skin Mass, Soft Tissue, Prostate, Stomach Pleural, Head and Neck, and Are at Risk of Recurrence
Conditions
Brief summary
The purpose of this registry is to monitor the rate of recurrence in patients who undergo cancer surgery.
Detailed description
Our objective is to collect prospective data on cancer subjects who undergo surgery and intraoperative imaging. The registry will include (but not limited to) cancer type, stage, intraoperative challenges to the surgeon, usage and results of intraoperative imaging, and recurrence surveillance. In this protocol, subjects that receive intraoperative imaging will provide us the opportunity to record what tissues fluoresce in the operating room, and then to identify if these lesions are cancer when the histopathology is performed. Also, we will monitor any side effects or potential toxicities that may occur. This data can then be used to predict if a subject is more likely to develop a local recurrence due to missed cancer cells, metastatic lymph nodes or synchronous lesions.
Interventions
OTHERRegistry
Sponsors
Abramson Cancer Center at Penn Medicine
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Inclkusion Criteria * Adult patients \>= 18 years of age * Patients presenting with any solid tumor and/or diseased tissue even benign nodules presumed to be resectable and are at risk for recurrence. * Good operative candidate as determined by the treating physician and/or multidisciplinary team * Subject capable of giving informed consent and participating in the process of consent.
Exclusion criteria
None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of subjects registered | 2 years |
Countries
United States
Outcome results
None listed